NASDAQ:DBVT
DBV Technologies S.A. Stock News
$0.661
-0.0207 (-3.04%)
At Close: Apr 22, 2024
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
04:30pm, Monday, 04'th Mar 2024
Montrouge, France, March 4, 2024 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stoc
Top 5 Health Care Stocks That Could Blast Off In December - DBV Technologies (NASDAQ:DBVT), Cigna Group (NYSE:CI)
10:47am, Friday, 01'st Dec 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Down -25.23% in 4 Weeks, Here's Why You Should You Buy the Dip in DBV Technologies S.A. (DBVT)
11:19am, Monday, 27'th Nov 2023
DBV Technologies S.A. (DBVT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.
DBV Technologies to Present New Data at ACAAI 2023
04:30pm, Thursday, 02'nd Nov 2023
Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12-month results from the ongoing Phase 3 open-label
DBV Technologies S.A. (DBVT) Q3 2023 Earnings Call Transcript
09:57pm, Tuesday, 31'st Oct 2023
DBV Technologies S.A. (NASDAQ:DBVT ) Q3 2023 Earnings Conference Call October 31, 2023 5:00 PM ET Company Participants Katie Matthews - Head of Investor Relations Daniel Tassé - Chief Executive Offic
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
04:30pm, Friday, 27'th Oct 2023
Montrouge, France, October 27, 2023 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market:
DBV Technologies to Participate in Upcoming Investor Conference
04:30pm, Tuesday, 05'th Sep 2023
Montrouge, France, September 5, 2023 D BV Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
04:30pm, Tuesday, 25'th Jul 2023
Montrouge, France, July 25, 2023 DBV Technologies to Report First Half 202 3 Financial Results and Provide a Corporate Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Ma
DBV Technologies to Participate in Upcoming Investor Conference
05:00pm, Tuesday, 06'th Jun 2023
Montrouge, France, June 06, 2023 DB V Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stag
Why Shares of DBV Technologies Jumped Thursday
03:31pm, Thursday, 11'th May 2023
The company's peanut allergy treatment patch could have a wide impact. DBV Technologies currently has no marketed products.
DBV Technologies to Participate in Upcoming Investor Conference
04:30pm, Tuesday, 09'th May 2023
Montrouge, France, May 9, 2023 D BV Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
7 Penny Stocks Sitting in the Sweet Spot
02:03pm, Sunday, 26'th Mar 2023
While penny stocks almost always attract investors' attention at some point, they're also wildly unpredictable and risky. Yes, some people do enjoy lifechanging profitability.
Mise à jour DBV Technologies
05:30am, Monday, 13'th Mar 2023 GlobeNewswire Inc.
Montrouge, France, le 13 mars 2023
DBV Technologies Update
05:30am, Monday, 13'th Mar 2023 GlobeNewswire Inc.
Montrouge, France, March 13, 2023
DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old
09:30pm, Tuesday, 07'th Mar 2023 GlobeNewswire Inc.
Montrouge, France, March 7, 2023
